Search

The Merkin Prize Jury is composed of scientific leaders from academia and industry in the US and Europe.

Carl June University of Pennsylvania Perelman School of Medicine Carl June is the Richard W. Vague professor in immunotherapy at the Perelman School of Medicine at the University of Pennsylvania, where he is also the director of the Center for Cellular Immunotherapies. In addition, he is the...

October 31, 2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy Produced by the Heritage Provider Network video team This groundbreaking form of personalized cancer immunotherapy...

FOR IMMEDIATE RELEASE CONTACT Karen Zusi-Tran Broad Institute kzusi@broadinstitute.org Janet Janjigian Heritage Provider Network janjigianj@carmengroup.com 424-354-0133 The winners are Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain, who developed technology that reprograms patients’...

This groundbreaking form of personalized cancer immunotherapy has had remarkable success — more than 45,000 cancer patients worldwide have been treated with CAR T-cell therapy, extending their lives and, in many cases, delivering complete and sustained remissions.

Nominations for the 2026 Merkin Prize have closed. Nominations for the 2027 Prize open in August 2026. Join the Merkin Prize mailing list to receive updates and notifications. Join mailing list